摘要
本文对42例原发性肝癌经顺铂微球碘化油化疗栓塞A组22例,和化疗药物碘化油栓塞B组20例,作疗效比较:1.肿瘤缩小率:A组占85%,B组占70%。2.生存率:A组6月、12月、18月及24月的生存率分别为72%、45%、23%及4.5%;B组分别为60%、25%、5%及0%。平均生存期A组10.6月、B组7.6月。顺铂微球加碘化油栓塞的效果明显高于化疗药物碘化油栓塞的效果。是治疗肝癌有效方法之一。并讨论了顺铂微球化疗栓塞的适应症,术后并发症及其处理原则。
42 patients A and B with primary liver cancer were randomly divided into two gronps:20 Patients in group A with lipiodol plus CDDP-microspheres and 22 patients in group B with lipiodol anticancer durg emulsion.The results revealed:1.Tumor diminution in 85% patients in group A and 70% patients in group B.2.The cumulative survival rates at 6, 12, 18and 24 months were 72%, 45%, 23% and 4.5% in group A and 60%, 25%, 5% and 0% in group B respectively.The mean survival time was 10.6 months and 7.6 months in group A and group B respectively.The results of therapeutic effects of group A were obviously better than group B suggesting arterial chemo-enbolizsa-tion by lipiodol plus CDDP-microspheres should be the preferable method of choice, and its indications and complications (includiig management)were discussed.
出处
《介入放射学杂志》
CSCD
1992年第C00期27-30,共4页
Journal of Interventional Radiology